Literature DB >> 10673455

Isotretinoin induced rhabdomyolysis? A case report.

M A Trauner1, B S Ruben.   

Abstract

Isotretinoin, an effective therapy for nodulocystic acne and dissecting cellulitis of the scalp, has many known side effects. However, its association with elevated creatine kinase levels and its potential to cause rhabdomyolysis is not well established. We describe a patient with a significant elevation in creatine kinase after beginning therapy with isotretinoin for dissecting cellulitis of the scalp. The implications of isotretinoin causing rhabdomyolysis are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10673455

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  8 in total

1.  Exertional paraspinal muscle rhabdomyolysis and compartment syndrome: a cause of back pain not to be missed.

Authors:  Lori Wik; Jeffrey M Patterson; Anna E Oswald
Journal:  Clin Rheumatol       Date:  2010-02-11       Impact factor: 2.980

2.  Severe generalised rhabdomyolysis with fatal outcome associated with isotretinoin.

Authors:  Benno Hartung; Hans F Merk; Wolfgang Huckenbeck; Thomas Daldrup; Eva Neuen-Jacob; Stefanie Ritz-Timme
Journal:  Int J Legal Med       Date:  2012-08-16       Impact factor: 2.686

Review 3.  Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians.

Authors:  Elisabeth Chroni; Alexandra Monastirli; Dionysios Tsambaos
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

4.  Sacroiliitis and severe disability due to isotretinoin therapy.

Authors:  Alexander P Rozin; Olga Kagna; Yizhak Shiller
Journal:  Rheumatol Int       Date:  2009-06-17       Impact factor: 2.631

5.  Effect of oral isotretinoin on muscle strength in patients with acne vulgaris: a prospective controlled study.

Authors:  Cevriye Mülkoğlu; Nermin Karaosmanoğlu
Journal:  BMC Pharmacol Toxicol       Date:  2021-03-20       Impact factor: 2.483

6.  Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study.

Authors:  Emine Müge Acar; Senem Şaş; Fatmanur Aybala Koçak
Journal:  Arch Rheumatol       Date:  2021-12-24       Impact factor: 1.007

7.  Creatine Phosphokinase Values during Low Starting Dose Isotretinoin Therapy.

Authors:  Marco Manfredini; Vincenzo Bettoli; Riccardo Forconi; Lucrezia Pacetti; Francesca Farnetani; Monica Corazza; Giovanni Pellacani
Journal:  Skin Appendage Disord       Date:  2020-05-05

8.  A Common Drug With a Dangerous Side Effect: Acute Rhabdomyolysis Caused by the Synergistic Effect of Isotretinoin and Exercise in an Adolescent.

Authors:  Kingshuk Dasgupta; Peter Lim; Hannah Reedstorm
Journal:  Cureus       Date:  2020-10-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.